Hi@FloatingCityRef your post 74148115 because the reply thingy...

Hi@FloatingCity
Ref your post 74148115 because the reply thingy is broken (again)

Up front, I know nothing more than you here..
I think we will see a lot of activity over the coming few weeks to promote why PAA is so undervalued and why it is a good investment.
For example:

• We have been told to expect the OLE entry data which can only be good news.
• We might see some results from "brain in a dish" pre-clinical work.
• We might see a grant confirmed,
• We could see a commercial agreement for some aspect.
• Much more....

The strategy for funding is likely on numerous fronts however tactically shifting day by day as this is now quite dynamic with ODD plus the new structure in place.Sorry, can't help beyond knowing the dilution of shares is not desirable (Marcus told me this was a priority for him as a shareholder, well before all of the changes even were a thing) but may be required to some degree and the board will work hard to get the best outcome for shareholders.